FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

32897911000001104: Daklinza 90mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 20-Jul 2016. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
100261501000001113 Daklinza 90mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
100261601000001112 Daklinza 90mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Daklinza 90mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) Has specific active ingredient Daclatasvir dihydrochloride true Inferred relationship Existential restriction modifier
Daklinza 90mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Daklinza 90mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Daklinza 90mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Daklinza 90mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) Is a Daclatasvir 90mg tablets true Inferred relationship Existential restriction modifier
Daklinza 90mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) Has active ingredient Daclatasvir true Inferred relationship Existential restriction modifier
Daklinza 90mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Daklinza 90mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Daklinza 90mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) Has specific active ingredient Daclatasvir dihydrochloride false Inferred relationship Existential restriction modifier
Daklinza 90mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Daklinza 90mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Daclatasvir false Inferred relationship Existential restriction modifier
Daklinza 90mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Daklinza 90mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Daklinza 90mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) Is a Daklinza true Inferred relationship Existential restriction modifier
Daklinza 90mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Daklinza 90mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) Has basis of strength substance Daclatasvir true Inferred relationship Existential restriction modifier
Daklinza 90mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Daklinza 90mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) 28 tablet 2 x 14 tablets Has AMP True Daklinza 90mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start